Public Educational Seminar on Adipose Derived Stem Cell Treatments

Find out how the Irvine Stem Cell Treatment Center is at the forefront of adipose derived stem cell research for such conditions as Heart Failure, Emphysema, COPD, Asthma, Parkinson’s Disease, Stroke, Multiple Sclerosis, and orthopedic joint injections.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Irvine, California (PRWEB) February 08, 2014

The Irvine Stem Cell Treatment Center, PC, located in Irvine, California, announces a series of free public seminars on the use of stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief.

The seminars will be held on February 9th and 11th. On February 9th, the seminar will be held at 3500 Barranca Pkwy, Suite 315, Irvine, California at 2pm. On February 11th, the seminar will be held at the University of Claremont in the Padua Room of the Alexander Hughes Community Center, 1700 Danbury Road, Claremont, California at 11:30am.

At the Irvine Stem Cell Treatment Center, utilizing investigational protocols, adult adipose derived stem cells (ADSCs) can be deployed to improve patients’ quality of life with a number of degenerative conditions and diseases. ADSCs are taken from the patient’s own adipose (fat) tissue (also called stromal vascular fraction (SVF)). Adipose tissue is exceptionally abundant in ADSCs. The adipose tissue is obtained from the patient during a 15 minute mini-liposuction performed under local anesthesia in the doctor’s office. SVF is a protein-rich solution containing mononuclear cell lines (predominantly autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important Growth Factors that facilitate the stem cell process and promote their activity.

ADSCs are the body's natural healing cells - they are recruited by chemical signals emitted by damaged tissues to repair and regenerate the body’s damaged cells. The Irvine Stem Cell Treatment Center only uses autologous stem cells from a person's own fat – no embryonic stem cells are used. Our current areas of study include: Heart Failure, Emphysema, COPD, Asthma, Parkinson’s Disease, Stroke, Multiple Sclerosis, and orthopedic joint injections. For more information, or if someone thinks they may be a candidate for one of the stem cell protocols offered by Irvine Stem Cell Treatment Center, they may contact Dr. Gionis directly at (949) 679-3889, or see a complete list of the Center’s study areas at: http://www.StemCellsUSA.net.

About Irvine Stem Cell Treatment Center:
The Irvine Stem Cell Treatment Center is an affiliate of the Cell Surgical Network (CSN). We provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment. We utilize a fat transfer surgical technology to isolate and implant the patient’s own stem cells from a small quantity of fat harvested by a mini-liposuction on the same day. The investigational protocols utilized by the Irvine Stem Cell Treatment Center have been reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Research Protections; and the study is registered with Clinicaltrials.gov, a service of the U.S. National Institutes of Health (NIH). For more information contact: Info(at)StemCellsUSA(dot)net or visit our website: http://www.stemcellsusa.net.